Administration of G-CSF after autologous peripheral stem cell transplantation is clinical and cost-effective

被引：0
|
作者：
Fruchart, C [1 ]
Journet, V [1 ]
Damourette, S [1 ]
Rivière, A [1 ]
German, O [1 ]
Musafiri, D [1 ]
Peny, AM [1 ]
机构：
[1] Ctr Francois Baclesse, F-14021 Caen, France
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [31] Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma
    P Mollee
    D Pereira
    T Nagy
    K Song
    R Saragosa
    A Keating
    M Crump
    Bone Marrow Transplantation, 2002, 30 : 273 - 278
  • [32] Cost effectiveness of G-CSF after allogeneic peripheral blood stem cell transplant.
    Singh, Vijendra
    Kim, Seongho
    Jang, Hyejeong
    Alavi, Asif
    Bhutani, Divaya
    Ayash, Lois Jeanne
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Deol, Abhinav
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Delayed administration of G-CSF until day+7 after autologous peripheral blood stem cell transplant is as effective in accelerating hematopoitic as day 0
    Sobrevilla-Calvo, P
    Sierra, JWZ
    Medina, FUL
    Barreda, AA
    Flores, EC
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2002, 54 (01): : 51 - 56
  • [34] Stem Cell Mobilization With Plerixafor plus G-CSF In Comparison To Cyclophosphamide plus G-CSF and Time-To-Progression After Autologous Stem Cell Transplantation For Multiple Myeloma
    Garfall, Alfred L.
    Dougherty, Andrew
    Vogl, Dan T.
    Weiss, Brendan M.
    Cohen, Adam D.
    Porter, David L.
    O'Doherty, Una
    Mangan, Patricia
    Cunningham, Kathleen
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2013, 122 (21)
  • [35] G-CSF IS AN EFFECTIVE SUPPORTIVE MODALITY IN PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION
    SCHWARTZBERG, L
    BIRCH, R
    HEFFERNAN, M
    WEST, W
    BLOOD, 1993, 82 (10) : A286 - A286
  • [36] Biosimilar G-CSF (filgrastim) is also efficient for peripheral blood stem cell mobilisation and no cryopreserved autologous transplantation
    Yafour, N.
    Osmani, S.
    Talhi, S.
    Brahimi, M.
    Hebbar, A.
    Bekadja, S.
    Mehalli, S.
    Benmir, I.
    Arabi, A.
    Bouhass, R.
    Bekadja, M. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S243 - S243
  • [37] At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study
    Martinez-Cibrian, N.
    Magnano, L.
    Gutierrez-Garcia, G.
    Andrade, X.
    Correa, J. G.
    Suarez-Lledo, M.
    Martinez, C.
    Rovira, M.
    Carreras, E.
    Rosinol, L.
    de Larrea, C. F.
    Cibeira, M. T.
    Gaya, A.
    Gallego, C.
    Hernando, A.
    Creus, N.
    Blade, J.
    Urbano-Ispizua, A.
    Fernandez-Aviles, F.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 593 - 595
  • [38] Autologous stem cell transplantation (APSCT) with G-CSF primed peripheral blood in acute myelogenous leukemia (AML)
    Rio, B
    Boccaccio, C
    Belhocine, R
    Perrot, JY
    Zittoun, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 344 - 344
  • [39] Delayed Administration of Filgrastim (G-CSF) Following Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) in Pediatric Patients Does Not Change Time to Neutrophil Engraftment and Reduces Use of G-CSF
    Pai, Vinita
    Fernandez, Soledad A.
    Laudick, Melissa
    Rosselet, Robin
    Termuhlen, Amanda
    PEDIATRIC BLOOD & CANCER, 2010, 54 (05) : 728 - 733
  • [40] At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study
    N Martínez-Cibrian
    L Magnano
    G Gutiérrez-García
    X Andrade
    J G Correa
    M Suárez-Lledó
    C Martínez
    M Rovira
    E Carreras
    L Rosiñol
    C F de Larrea
    M T Cibeira
    A Gaya
    C Gallego
    A Hernando
    N Creus
    J Bladé
    Á Urbano-Ispizua
    F Fernández-Avilés
    Bone Marrow Transplantation, 2016, 51 : 593 - 595
12345